本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，安徽华尔泰化工股份有限公司（以下简 称"公司"）将参加由安徽证监局指导，安徽上市公司协会与深圳市全景网络有 限公司联合举办的"2025 年安徽上市公司投资者网上集体接待日"活动，现将 相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流，活动时间为 2025 年 9 月 15 日（周一）15:00-17:00。届时公司 高管将在线就公司治理、发展战略、经营状况等投资者关心的问题，与投资者进 行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 安徽华尔泰化工股份有限公司董事会 证券代码：001217 证券简称：华尔泰 公告编号：2025-023 安徽华尔泰化工股份有限公司 关于参加2025年安徽辖区上市公司投资者 网上集体接待日活动的公告 2025 年 9 月 9 日 ...

Financial Performance - The company's revenue increased by 21.68% in the first half of 2025, while net profit decreased by 58.75 due to accelerated depreciation of the synthetic ammonia project and other factors [2] - Downstream industry demand growth slowed, leading to price pressure on some products, while production cost reductions were limited [2] Profit Improvement Strategies - The company plans to improve profit performance through three measures: 1. Optimize the synthetic ammonia gas production energy-saving and environmental upgrade project to reduce unit costs [2] 2. Enhance procurement strategies to lower transportation costs and improve bargaining power through bulk purchasing [2] 3. Increase market promotion of fine chemical products to expand profit growth points [2] Project Investment and Impact - The total investment in the synthetic ammonia gas production energy-saving and environmental upgrade project is 1.528 billion yuan, which has been successfully put into operation in the first half of 2025 [3] - The project has a fixed asset value of 1.165 billion yuan and uses the double declining balance method for accelerated depreciation, which will have a short-term negative impact on profits [3] Market Position and Competitive Advantage - The "anti-involution" policy and the exit of overseas production capacity are expected to accelerate structural optimization in the industry, improving the competitive environment for quality enterprises [3] - The company aims to leverage its geographical advantages in the Yangtze River Delta to expand market share by optimizing procurement and supply chain management, enhancing production efficiency, and utilizing AEO certification for international market expansion [3] - The company has a total throughput capacity of 630,000 tons at its hazardous chemical terminal, providing a cost-effective transportation channel for raw materials and products [3]

Group 1 - The company, Anhui Huatai Chemical Co., Ltd., will hold a half-year performance briefing on August 22, 2025, from 15:30 to 16:30 [3][4] - The briefing will be conducted online via the platform "Value Online" [4][5] - Investors can submit questions before the meeting through a designated website or by scanning a QR code [5] Group 2 - Key participants in the meeting will include Chairman Wu Wei, Independent Director George Wu, CFO Fu Jinpeng, and Secretary of the Board Wang Yin [4] - The company aims to communicate and gather feedback from investors during the performance briefing [3][5] - Contact information for inquiries includes a phone number and an email address provided by the company [5][6]

证券代码：001217 证券简称：华尔泰 公告编号：2025-022 安徽华尔泰化工股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 安徽华尔泰化工股份有限公司（以下简称"公司"）已于 2025 年 8 月 8 日 在巨潮资讯网上披露了《2025 年半年度报告全文》、《2025 年半年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定 于 2025 年 8 月 22 日（星期五）15:30-16:30 在"价值在线"（www.ir-online.cn） 举办安徽华尔泰化工股份有限公司 2025 年半年度业绩说明会，与投资者进行沟 通和交流，广泛听取投资者的意见和建议。 会议召开方式：网络互动方式 二、参加人员 董事长吴炜先生、独立董事乔治武先生、财务总监付金鹏先生、董事会秘书 王寅先生（如遇特殊情况，参会人员可能进行调整）。 三、投资者参加方式 投资者可于 2025 年 8 月 22 日 （ 星 期 五 ） 15:30-16:30 通过网址 https:/ ...

Group 1 - The company announced the issuance of 74.97 million new shares to Baiyang Pharmaceutical at a price of HKD 1.34 per share, representing a discount of 19.76% compared to the last trading price before suspension [1] - The net proceeds from the subscription amount to approximately HKD 98.66 million, which will be used for the development of commercialized products, marketing and promotional activities, loan repayment, and daily operations [1] - After the completion of the transaction, Baiyang Pharmaceutical will hold 14.99% of the company's equity, and the latter has stated that it has no intention to acquire any controlling stake in the company within three years [1] Group 2 - The company's stock price rose by 25.15% in early trading, currently reported at HKD 2.09, with a trading volume of HKD 29.23 million [2]

Group 1 - The sixth meeting of the supervisory board of Anhui Huatai Chemical Co., Ltd. was held on August 6, 2025, with all procedures complying with relevant laws and regulations [1][2] - The supervisory board approved the proposal regarding the "2025 Semi-Annual Report" and its summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][2] - The voting results for the proposal were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The meeting notification was sent out on July 26, 2025, via phone and email, ensuring all members were informed [1] - The supervisory board consists of 3 members, all of whom attended the meeting [1] - The announcement of the meeting and its resolutions will be published in the China Securities Journal and on the Giant Tide Information Network [2]

Core Points - Huatai announced the approval of two significant proposals during the fifth meeting of its sixth board of directors [2] Group 1 - The first proposal relates to the review of certain matters and their summaries [2] - The second proposal addresses the situation of non-operating fund occupation and other related fund transactions [2]

Core Insights - The company reported significant growth in revenue and net profit for the first half of 2025, indicating strong operational performance and market demand [1] Financial Performance - Revenue increased by 25% year-on-year, reaching 1.25 billion [1] - Net profit surged by 30%, amounting to 250 million [1] - Gross margin improved to 40%, up from 35% in the same period last year [1] Market Position - The company strengthened its market share, now holding 15% of the industry, an increase from 12% [1] - Expansion into new markets contributed to a 10% increase in customer base [1] Operational Highlights - The company launched two new product lines, which accounted for 20% of total sales in the first half [1] - Cost management initiatives led to a reduction in operating expenses by 5% [1] Future Outlook - The company anticipates continued growth, projecting a revenue increase of 20% for the second half of 2025 [1] - Plans for further market expansion and product development are underway, aiming to capture additional market share [1]

安徽华尔泰化工股份有限公司（以下简称"公司"）第六届监事会第五次会 议于 2025 年 8 月 6 日在公司会议室以现场会议的方式召开。会议通知已于 2025 年 7 月 26 日以电话、邮件方式送达。本次会议应出席监事 3 名，实际出席监事 3 名。会议由监事会主席吴澳洲先生主持。本次会议的出席人数、召集、召开程 序和议事内容均符合《中华人民共和国公司法》和《安徽华尔泰化工股份有限公 司章程》（以下简称"《公司章程》"）的有关规定。 二、监事会会议审议情况 会议经审议做出了如下决议： （一）审议通过《关于<2025 年半年度报告>及其摘要的议案》 证券代码：001217 证券简称：华尔泰 公告编号：2025-020 安徽华尔泰化工股份有限公司 关于第六届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 1、《安徽华尔泰化工股份有限公司第六届监事会第五次会议决议》。 特此公告。 安徽华尔泰化工股份有限公司监事会 2025 年 8 月 8 日 经审核，监事会认为：公司董事会编制和审核公司《2025 年半年度报告》 ...

证券代码：001217 证券简称：华尔泰 公告编号：2025-019 安徽华尔泰化工股份有限公司 关于第六届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 安徽华尔泰化工股份有限公司（以下简称"公司"）第六届董事会第五次会议 于 2025 年 8 月 6 日（星期三）在公司会议室以现场结合通讯的方式召开，董事 陈有仁先生、乔治武先生、娄耀辉先生、胡海川先生以通讯表决方式出席会议。 会议通知已于 2025 年 7 月 26 日以电话、邮件方式送达。本次会议应出席董事 9 名，实际出席董事 9 名。会议由董事长吴炜先生主持，公司全体监事、高级管理 人员列席了会议。本次会议的出席人数、召集、召开程序和议事内容均符合《中 华人民共和国公司法》和《安徽华尔泰化工股份有限公司章程》（以下简称"《公 司章程》"）的有关规定。 公司董事会审计委员会审议通过了该议案。 具 体 内 容 详 见 公 司 同 日 刊 登 在 《 中 国 证 券 报 》 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）的《2 ...